当前位置:首页 - 行情中心 - 春立医疗(688236) - 财务分析 - 现金流量表

春立医疗

(688236)

  

流通市值:37.64亿  总市值:50.06亿
流通股本:2.88亿   总股本:3.84亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金587,450,402.07377,757,473.92141,900,211.931,162,512,413.23
  收到的税费返还846,367.28--2,825,763.95
  收到其他与经营活动有关的现金22,740,576.0715,710,516.496,027,991.2752,637,106.33
  经营活动现金流入小计611,037,345.42393,467,990.41147,928,203.21,217,975,283.51
  购买商品、接受劳务支付的现金182,786,432.33127,937,374.7967,926,712.43375,083,907.55
  支付给职工以及为职工支付的现金136,014,227.83102,875,370.5245,064,602.87187,210,571.05
  支付的各项税费53,431,764.3446,452,984.3113,613,723.3447,771,951.17
  支付其他与经营活动有关的现金121,290,508.3781,880,247.0732,251,218.99203,068,928.66
  经营活动现金流出小计493,522,932.87359,145,976.69158,856,257.63813,135,358.43
  经营活动产生的现金流量净额117,514,412.5534,322,013.72-10,928,054.43404,839,925.08
二、投资活动产生的现金流量:
  收回投资收到的现金790,000,000790,000,000-1,689,000,000
  取得投资收益收到的现金7,648,931.517,648,931.51-15,609,166.86
  处置固定资产、无形资产和其他长期资产收回的现金净额87,0002,838-23,000
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计797,735,931.51797,651,769.51-1,704,632,166.86
  购建固定资产、无形资产和其他长期资产支付的现金31,522,559.6727,561,388.9819,994,053.259,127,974.35
  投资支付的现金725,000,000725,000,000-1,755,000,000
  取得子公司及其他营业单位支付的现金---2,200,000
  投资活动现金流出小计756,522,559.67752,561,388.9819,994,053.21,816,327,974.35
  投资活动产生的现金流量净额41,213,371.8445,090,380.53-19,994,053.2-111,695,807.49
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金137,588,993.64104,885,018.2880,249,991.7418,727,390.8
  支付其他与筹资活动有关的现金5,112,942.362,065,955.471,159,250.2110,787,049.43
  筹资活动现金流出小计142,701,936106,950,973.7581,409,241.9529,514,440.23
  筹资活动产生的现金流量净额-142,701,936-106,950,973.75-81,409,241.95-29,514,440.23
四、汇率变动对现金及现金等价物的影响-563,101.66-537,020.27-320,760.32-174,841.04
五、现金及现金等价物净增加额15,462,746.73-28,075,599.77-112,652,109.9263,454,836.32
  加:期初现金及现金等价物余额1,402,472,486.981,402,472,486.981,402,472,486.981,139,017,650.66
  期末现金及现金等价物余额1,417,935,233.711,374,396,887.211,289,820,377.081,402,472,486.98
补充资料:
  净利润-119,938,952.22-272,625,119.37
  资产减值准备-6,043,562.98-37,239,267.09
  固定资产和投资性房地产折旧-14,564,846.6-27,072,361.18
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-14,564,846.6-27,072,361.18
  无形资产摊销-4,828,907.31-12,503,614.76
  处置固定资产、无形资产和其他长期资产的损失----3,848.03
  固定资产报废损失--47,000.94--
  公允价值变动损失--3,648,527.39--8,742,663
  财务费用-613,766.96-213,991.25
  投资损失--2,818,027.41--6,315,413.45
  递延所得税--485,291.03--2,488,546.87
  其中:递延所得税资产减少-927,372.34--4,223,349.73
    递延所得税负债增加--1,412,663.37-1,734,802.86
  存货的减少-2,349,517.71--22,322,048.59
  经营性应收项目的减少--28,594,465.41-120,414,618.12
  经营性应付项目的增加--80,876,277.24--37,285,223.07
  现金的期末余额-1,374,396,887.21-1,402,472,486.98
  减:现金的期初余额-1,402,472,486.98-1,139,017,650.66
  现金及现金等价物的净增加额--28,075,599.77-263,454,836.32
公告日期2026-10-312026-08-292026-04-302026-03-31
审计意见(境内)标准无保留意见
TOP↑